The present invention provides protein kinase inhibitors comprising imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine compounds of the following structure (I) and (II):
or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof, wherein R, R
1
, R
2
and X are as defined herein. Compositions and methods for using the same in the treatment of cancer and other Pim kinase-associated conditions are also disclosed.
本发明提供蛋白激酶
抑制剂,包括以下结构(I)和(II)的
咪唑并[1,2-b]
吡啶和
吡唑并[1,5-a]
嘧啶化合物的立体异构体、前药或药物可接受的盐,其中R、R1、R2和X如本文所定义。还公开了在治疗癌症和其他Pim激酶相关疾病中使用这些化合物的组合物和方法。